Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2012, Article ID 964751, 4 pages
http://dx.doi.org/10.1155/2012/964751
Editorial

Adult Onset Still's Disease and Autoinflammation

1Rheumatology Division, Lincoln Medical & Mental Health Center, 234 E. 149th st, New York, NY 10451, USA
2Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA
3Division of Pediatric Rheumatology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 1 Robert Wood Johnson Place, New Brunswick, NJ 08901, USA
4Department of Physiology, School of Medicine, University of Athens, M. Asias 75, 11527 Athens, Greece
5Immunity & Inflammation Department, Regeneron Pharmaceuticals, Inc, 777 Old Saw Mill River Road Tarrytown, NY 10591, USA
6Pierre et Marie Curie University (Paris 6), Service de Rhumatologie, Groupe Hospitalier Pitié-Salpêtrière, 83 Boulevard de l'Hôpital, 75013 Paris, France

Received 26 June 2012; Accepted 26 June 2012

Copyright © 2012 Petros Efthimiou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Waite and D. Skokos, “Th17 response and inflammatory autoimmune diseases,” International Journal of Inflammation, vol. 2012, Article ID 819467, 10 pages, 2012. View at Publisher · View at Google Scholar
  2. B. Mehta and P. Efthimiou, “Ferritin in adult-onset Still's disease: just a useful innocent bystander?” International Journal of Inflammation, vol. 2012, Article ID 298405, 7 pages, 2012. View at Publisher · View at Google Scholar
  3. R. Gurion, T. J. Lehman, and L. N. Moorthy, “Systemic arthritis in children: a review of clinical presentation and treatment,” International Journal of Inflammation, vol. 2012, Article ID 271569, 16 pages, 2012. View at Publisher · View at Google Scholar
  4. E. G. Bywaters, “Still's disease in the adult,” Annals of the Rheumatic Diseases, vol. 30, no. 2, pp. 121–133, 1971. View at Google Scholar · View at Scopus
  5. J. B. Arlet, D. L. T. Huong, A. Marinho et al., “Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature,” Annals of the Rheumatic Diseases, vol. 65, no. 12, pp. 1596–1601, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. K. A. Boki, M. J. Tsirantonaki, K. Markakis, and H. M. Moutsopoulos, “Thrombotic thrombocytopenic purpura in adult Still's disease,” Journal of Rheumatology, vol. 23, no. 2, pp. 385–387, 1996. View at Google Scholar · View at Scopus
  7. M. Yamaguchi, A. Ohta, T. Tsunematsu et al., “Preliminary criteria for classification of adult Still's disease,” Journal of Rheumatology, vol. 19, no. 3, pp. 424–430, 1992. View at Google Scholar · View at Scopus
  8. B. Fautrel, E. Zing, J. L. Golmard et al., “Proposal for a new set of classification criteria for adult-onset still disease,” Medicine, vol. 81, no. 3, pp. 194–200, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. J. J. Cush, “Adult-onset Still's disease,” Bulletin on the Rheumatic Diseases, vol. 49, no. 6, pp. 1–4, 2000. View at Google Scholar · View at Scopus
  10. P. Efthimiou and S. Georgy, “Pathogenesis and management of adult-onset Still's disease,” Seminars in Arthritis and Rheumatism, vol. 36, no. 3, pp. 144–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Efthimiou, A. Kontzias, C. M. Ward, and N. S. Ogden, “Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?” Nature Clinical Practice Rheumatology, vol. 3, no. 6, pp. 328–335, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Colina, M. Govoni, and F. Trotta, “Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation,” Rheumatology International, vol. 29, no. 11, pp. 1355–1357, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. R. Collard and M. I. Schwarz, “Diffuse alveolar hemorrhage,” Clinics in Chest Medicine, vol. 25, no. 3, pp. 583–592, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Dino, G. Provenzano, G. Giannuoli, E. Sciarrino, M. Pouyet, and L. Pagliaro, “Fulminant hepatic failure in adult onset Still's disease,” Journal of Rheumatology, vol. 23, no. 4, pp. 784–785, 1996. View at Google Scholar · View at Scopus
  15. I. Kötter, A. Wacker, S. Koch et al., “Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature,” Seminars in Arthritis and Rheumatism, vol. 37, no. 3, pp. 189–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Y. Chen, J. L. Lan, F. J. Lin, and T. Y. Hsieh, “Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset still's disease,” Journal of Rheumatology, vol. 31, no. 11, pp. 2189–2198, 2004. View at Google Scholar · View at Scopus
  17. D. Y. Chen, Y. M. Chen, J. L. Lan, C. C. Lin, H. H. Chen, and C. W. Hsieh, “Potential role of th17 cells in the pathogenesis of adult-onset Still's disease,” Rheumatology, vol. 49, no. 12, pp. 2305–2312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Y. Chen, J. L. Lan, F. J. Lin, T. Y. Hsieh, and M. C. Wen, “Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease,” Annals of the Rheumatic Diseases, vol. 63, no. 10, pp. 1300–1306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. H. Choi, C. H. Suh, Y. M. Lee et al., “Serum cytokine profiles in patients with adult onset Still's disease,” Journal of Rheumatology, vol. 30, no. 11, pp. 2422–2427, 2003. View at Google Scholar · View at Scopus
  20. M. A. Scheinberg, E. Chapira, M. L. Fernandes, and O. Hubscher, “Interleukin 6: a possible marker of disease activity in adult onset Still's disease,” Clinical and Experimental Rheumatology, vol. 14, no. 6, pp. 653–655, 1996. View at Google Scholar · View at Scopus
  21. S. Colafrancesco, R. Priori, C. Alessandri et al., “IL-18 serum level in adult onset Still's disease: a marker of disease activity,” International Journal of Inflammation, vol. 2012, Article ID 156890, 6 pages, 2012. View at Publisher · View at Google Scholar
  22. M. E. Husni, A. L. Maier, P. J. Mease et al., “Etanercept in the treatment of adult patients with Still's disease,” Arthritis and Rheumatism, vol. 46, no. 5, pp. 1171–1176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Dechant, P. Schauenberg, C. E. Antoni, H. C. Kraetsch, J. R. Kalden, and B. Manger, “Longterm outcome of TNF blockade in adult-onset Still's disease,” Deutsche Medizinische Wochenschrift, vol. 129, no. 23, pp. 1308–1312, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Laskari, A. G. Tzioufas, and H. M. Moutsopoulos, “Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study,” Arthritis Research and Therapy, vol. 13, no. 3, article R91, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Perdan-Pirkmajer, S. Praprotnik, and M. Tomšič, “A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature,” Clinical Rheumatology, vol. 29, no. 12, pp. 1465–1467, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Thonhofer, M. Hiller, H. Just, M. Trummer, C. Siegel, and C. Dejaco, “Treatment of refractory adult-onset still's disease with tocilizumab: report of two cases and review of the literature,” Rheumatology International, vol. 31, no. 12, pp. 1653–1656, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Nakahara, T. Mima, N. Yoshio-Hoshino, M. Matsushita, J. Hashimoto, and N. Nishimoto, “A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years,” Modern Rheumatology, vol. 19, no. 1, pp. 69–72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Sumida, Y. Ubara, J. Hoshino et al., “Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab,” Clinical Rheumatology, vol. 29, no. 10, pp. 1191–1194, 2010. View at Google Scholar · View at Scopus
  29. J. Rech, M. Ronneberger, M. Englbrecht et al., “Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade,” Annals of the Rheumatic Diseases, vol. 70, no. 2, pp. 390–392, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Suematsu, A. Ohta, E. Matsuura et al., “Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan,” Modern Rheumatology. In press.
  31. L. Quartuccio, M. Maset, and S. De Vita, “Efficacy of abatacept in a refractory case of adult-onset Still's disease,” Clinical and Experimental Rheumatology, vol. 28, no. 2, pp. 265–267, 2010. View at Google Scholar · View at Scopus
  32. R. A. Ostrowski, R. Tehrani, and R. Kadanoff, “Refractory adult-onset still disease successfully treated with abatacept,” Journal of Clinical Rheumatology, vol. 17, no. 6, pp. 315–317, 2011. View at Google Scholar